There is lots of language...and the date of first publication to suggest it has nothing to do with UNS.
Its not to say that since this patent filing a number of device companies have come to the party with devices so less of a need for Abbott-Abbvie to do their own device like Roche etc. Rather they now have the simpler option is to buy the tech
Funny...up until yesterday Abbvie were one of the people i thought the UNS 1ml pump could do a deal for Humira especially since it was being trialled with Halozyme.
But Abbvie just pulled out if Humira-Halozyme development so that is a new variable. It can still be used with a pump and perhaps added no extra benefit but too early to really say.
UNS Price at posting:
5.7¢ Sentiment: None Disclosure: Not Held
